Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Esophageal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05461430
What this trial is testing

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Who this might be right for
Pleural Effusion, MalignantAscites, MalignantCarcinoma+29 more
Travera Inc 72
Early research (Phase 1)Looking for participantsNCT05954312
What this trial is testing

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Vividion Therapeutics, Inc. 290
Early research (Phase 1)Looking for participantsNCT06084481
What this trial is testing

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

Who this might be right for
Hepatocellular CarcinomaPancreatic Ductal AdenocarcinomaBiliary Tract Cancers+5 more
AbbVie 325
Testing effectiveness (Phase 2)Study completedNCT00069953
What this trial is testing

Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Esophageal Cancer
Radiation Therapy Oncology Group 43
Testing effectiveness (Phase 2)Temporarily pausedNCT05135845
What this trial is testing

Combination of Capmatinib + Spartalizumab in Advanced Oesogastric Adenocarcinoma

Who this might be right for
Oesophageal AdenocarcinomaGastric Adenocarcinoma
Assistance Publique - Hôpitaux de Paris 90
Not applicableStudy completedNCT01824966
What this trial is testing

Signet Ring Cell Carcinoma in Esophageal Adenocarcinoma

Who this might be right for
AdenocarcinomaEsophageal Cancer
University Hospital, Gasthuisberg 82
Early research (Phase 1)Study completedNCT02013154
What this trial is testing

DKN-01 in Combination With Paclitaxel or Pembrolizumab

Who this might be right for
Esophageal NeoplasmsAdenocarcinoma of the Gastroesophageal JunctionGastroesophageal Cancer+2 more
Leap Therapeutics, Inc. 151
Not applicableNot Yet RecruitingNCT07455422
What this trial is testing

Barrett's Esophagus Patients: Optimization of a Risk Model to Better Predict the Development of Cancer Recurrence and the Effect of Risk Profile Disclosure on Patient Quality of Life and Fear of Cancer

Who this might be right for
Barrett EsophagusBarrett Esophagus AdenocarcinomaAdenocarcinoma - GEJ+2 more
University Hospital, Antwerp 266
Not applicableStudy completedNCT01862666
What this trial is testing

A Comparison of Volumetric Laser Endomicroscopy (VLE) and Endoscopic Mucosal Resection (EMR) in Patients With Barrett's Dysplasia or Intramucosal Adenocarcinoma

Who this might be right for
Barrett'S-associated DysplasiaIntramucosal Adenocarcinoma
NinePoint Medical 30
Testing effectiveness (Phase 2)UnknownNCT03966118
What this trial is testing

Avelumab + Paclitaxel/ Ramucirumab (RAP) as Second Line Treatment in Gastro-esophageal Adenocarcinoma

Who this might be right for
Gastroesophageal Junction AdenocarcinomaAdenocarcinoma of the Stomach
P. C. Thuss-Patience 59
Testing effectiveness (Phase 2)Looking for participantsNCT04939051
What this trial is testing

Obeticholic Acid for Prevention in Barrett's Esophagus

Who this might be right for
Barrett EsophagusEsophageal Adenocarcinoma
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT01238042
What this trial is testing

Study To Determine The Maximum Range of Light Doses At Two HPPH Doses With Acceptable Normal Tissue Toxicity For PDT Treatment Of High Grade Dysplasia,CIS or Early Adenocarcinoma In Barrett's Esophagus

Who this might be right for
Barrett's EsophagusCISHGD
Roswell Park Cancer Institute 18
Not applicableStudy completedNCT02890979
What this trial is testing

Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease

Who this might be right for
Barrett EsophagusDysplasiaEsophageal Adenocarcinoma+3 more
OHSU Knight Cancer Institute 11
Not applicableUnknownNCT04269083
What this trial is testing

A Biomarker-driven Therapeutic Strategy for Esophageal Cancer Chemoradiotherapy in Patients With Resectable Adenocarcinoma of the ESophagus and Esophagogastric Junction

Who this might be right for
Esophageal Cancer
Azienda Ospedaliera Universitaria Integrata Verona 128
Early research (Phase 1)Ended earlyNCT03621982
What this trial is testing

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

Who this might be right for
Head and Neck Cancer Squamous Cell CarcinomaNon-small Cell Lung CancerGastric Cancer+9 more
ADC Therapeutics S.A. 78
Testing effectiveness (Phase 2)Study completedNCT02559687
What this trial is testing

Study of Pembrolizumab (MK-3475) in Previously-Treated Participants With Advanced Carcinoma of the Esophagus or Esophagogastric Junction (MK-3475-180/KEYNOTE-180)

Who this might be right for
Esophageal CarcinomaEsophagogastric Junction Carcinoma
Merck Sharp & Dohme LLC 121
Testing effectiveness (Phase 2)Study completedNCT00534001
What this trial is testing

Bupropion in Helping Adults Stop Smoking

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Roswell Park Cancer Institute 95
Not applicableLooking for participantsNCT04510129
What this trial is testing

Cancer Biospecimen Collection Study

Who this might be right for
Cancer of Head and NeckLung Cancer, Nonsmall CellSmall-cell Lung Cancer+8 more
Cofactor Genomics, Inc. 1,650
Testing effectiveness (Phase 2)Study completedNCT00711412
What this trial is testing

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Northwestern University 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07689292
What this trial is testing

Sac-TMT Combined With Fruquintinib as Second-Line Treatment in Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction (GEJ) AdenocarcinomaGastro-esophageal Junction Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital 45
Next Page